Primary pericardial angiosarcoma: A case report

J Nucl Cardiol. 2022 Oct;29(5):2734-2737. doi: 10.1007/s12350-020-02470-0. Epub 2021 Feb 8.

Abstract

Primary pericardial angiosarcoma is a rare malignant cardiac neoplasm with early metastasis and poor prognosis. There are currently no guidelines or effective therapeutic strategies. Here we report a case of a 22-year-old man who presented with chest pain, suffocation and transient syncope over the course of 4 months. Further workup showed a large mass in the right pericardium, histopathologic examination revealed angiosarcoma. The patient subsequently received a total of 8 cycles of chemotherapy (paclitaxel and doxorubicin). This patient has an overall survival of 1 year to date. The current examination methods and reported cases revealed that early detection of primary pericardial angiosarcoma with imaging examinations is critical for prognosis.

Keywords: Chemotherapy; Primary pericardial angiosarcoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Doxorubicin
  • Heart Neoplasms* / diagnostic imaging
  • Hemangiosarcoma* / diagnostic imaging
  • Hemangiosarcoma* / pathology
  • Humans
  • Male
  • Mediastinal Neoplasms*
  • Paclitaxel
  • Pericardium / diagnostic imaging
  • Pericardium / pathology
  • Thymus Neoplasms*
  • Young Adult

Substances

  • Doxorubicin
  • Paclitaxel